Recovery research fieldbook Evidence, not treatment advice
Recovery archive

Published recovery field note

What Does CJC-1295 Peptide Do?

One of the reasons CJC-1295 has become so popular is the range of benefits it offers. Because it works with your body’s own hormonal pathways rather than introducing external growth hormones directly, many patients experience improvements that feel natural and progressive. Here are some of the most well-documented benefits: References: Alba, M., Fintini, D., Sagazio, A., Lawrence, B., Castaigne, J. P., Frohman, L. A., & Salvatori, R. (2006). Once-daily administration of CJC-1295, a long-acting growth hormone-releasing hormone (GHRH) analog, normalizes growth in the GHRH knockout mouse. American Journal of Physiology-Endocrinology and Metabolism, 291(6), E1290–E1294. https://pubmed.ncbi.nlm.nih.gov/16822960/ Ionescu, M., & Frohman, L. A. (2006). Pulsatile secretion of growth hormone (GH) persists during continuous stimulation by CJC-1295, a long-acting GH-releasing hormone analog. Journal of Clinical Endocrinology & Metabolism, 91(12), 4792–4797. https://pubmed.ncbi.nlm.nih.gov/17018654

Context first

Study findings do not automatically establish clinical benefit, safety, dosing, or suitability for an individual.

One of the reasons CJC-1295 has become so popular is the range of benefits it offers. Because it works with your body’s own hormonal pathways rather than introducing external growth hormones directly, many patients experience improvements that feel natural and progressive. Here are some of the most well-documented benefits:

References:

Alba, M., Fintini, D., Sagazio, A., Lawrence, B., Castaigne, J. P., Frohman, L. A., & Salvatori, R. (2006). Once-daily administration of CJC-1295, a long-acting growth hormone-releasing hormone (GHRH) analog, normalizes growth in the GHRH knockout mouse. American Journal of Physiology-Endocrinology and Metabolism, 291(6), E1290–E1294. https://pubmed.ncbi.nlm.nih.gov/16822960/

Ionescu, M., & Frohman, L. A. (2006). Pulsatile secretion of growth hormone (GH) persists during continuous stimulation by CJC-1295, a long-acting GH-releasing hormone analog. Journal of Clinical Endocrinology & Metabolism, 91(12), 4792–4797. https://pubmed.ncbi.nlm.nih.gov/17018654/

Sackmann-Sala, L., Ding, J., Frohman, L. A., & Kopchick, J. J. (2009). Activation of the GH/IGF-1 axis by CJC-1295, a long-acting GHRH analog, results in serum protein profile changes in normal adult subjects. Growth Hormone & IGF Research, 19(6), 471–477. https://pmc.ncbi.nlm.nih.gov/articles/PMC2787983/

Teichman, S. L., Neale, A., Lawrence, B., Gagnon, C., Castaigne, J. P., & Frohman, L. A. (2006). Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults. Journal of Clinical Endocrinology & Metabolism, 91(3), 799–805. https://pubmed.ncbi.nlm.nih.gov/16352683/

Teichman, S. L., Neale, A., Lawrence, B., Gagnon, C., Castaigne, J. P., & Frohman, L. A. (2006). Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults. The Journal of Clinical Endocrinology & Metabolism, 91(3), 799–805. https://academic.oup.com/jcem/article-abstract/91/3/799/2843281

Connected topics

Follow this recovery question